FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113067327> ?p ?o ?g. }

• W3113067327 abstract "OBJECTIVES primary biliary cholangitis (PBC) is a chronic cholestatic disease, characterized by positive anti-mitochondrial autoantibodies (AMA) in 90-95 % patients. Anti-kelch-like 12 (anti-KLHL12) and anti-hexokinase1 (anti-HK1) antibodies have been identified as the two new serum markers in recent years, which are used in the diagnosis of AMA-negative PBC patients. The objective of the study was to examine the performance of these two new biomarkers in China. METHODS a total of 192 patients were enrolled and screened for anti-KLHL12 and anti-HK1 antibodies and AMA by ELISA. Receiver operating characteristic (ROC curve) analysis was applied to examine the diagnostic importance of AMA, anti-KLHL12 and anti-HK1 antibodies. Furthermore, correlation analysis between some important biochemical indexes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase [ALP], bilirubin, gamma-glutamil transferasa [γ-GT]), staging of pathological changes of the liver and the expression of novel antibodies in PBC patients were also examined. RESULTS the positivity of the anti-HK1 antibody in AMA-positive PBC patients and AMA-negative patients was 44.7 % and 33.3 %, respectively. The specificity, proportion of positive patients (PPV) and proportion of negative patients (NPV) were 93 %, 89 % and 53 %, respectively. In contrast, the positivity to the anti-KLHL12 antibody in AMA-positive and negative PBC patients was 41.2 % and 22.2 %, respectively. Specificity, PPV and NPV were 98 %, 95 % and 52 %, respectively. The area under the curve (AUC) with anti-HK1 and anti-KLHL12 antibodies were 0.720 and 0.703. With the combination with anti-HK1 and anti-KLHL12 antibodies, the AUC of AMA increased from 0.889 to 0.891, increasing the sensitivity from 0.764 to 0.836. Anti-KLHL12 and anti-HK1-positive patients had higher serum levels of ALP, γ-GT and bilirubin, with statistically significant differences (p < 0.01) compared with anti-KLHL12 or anti-HK1-negative patients. Notably, correlation analysis showed a significant positive correlation between antibody expression and ALP, γ-GT and bilirubin serum levels (r = 0.735, 0.491, 0.466; p < 0.01). CONCLUSIONS anti-HK1 and anti-KLHL12 antibodies have been identified as two significant biomarkers in PBC patients. Furthermore, the presence of these antibodies is likely to correlate with the severity of PBC." @default.
• W3113067327 created "2020-12-21" @default.
• W3113067327 creator A5018352694 @default.
• W3113067327 creator A5038635008 @default.
• W3113067327 creator A5082548608 @default.
• W3113067327 date "2020-01-01" @default.
• W3113067327 modified "2023-10-10" @default.
• W3113067327 title "Detection of Anti-kelch-like 12 and Anti-hexokinase 1 Antibodies in Primary Biliary Cholangitis Patients in China" @default.
• W3113067327 doi "https://doi.org/10.17235/reed.2020.7483/2020" @default.
• W3113067327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33307711" @default.
• W3113067327 hasPublicationYear "2020" @default.
• W3113067327 type Work @default.
• W3113067327 sameAs 3113067327 @default.
• W3113067327 citedByCount "1" @default.
• W3113067327 countsByYear W31130673272021 @default.
• W3113067327 crossrefType "journal-article" @default.
• W3113067327 hasAuthorship W3113067327A5018352694 @default.
• W3113067327 hasAuthorship W3113067327A5038635008 @default.
• W3113067327 hasAuthorship W3113067327A5082548608 @default.
• W3113067327 hasBestOaLocation W31130673271 @default.
• W3113067327 hasConcept C126322002 @default.
• W3113067327 hasConcept C142724271 @default.
• W3113067327 hasConcept C159654299 @default.
• W3113067327 hasConcept C160160445 @default.
• W3113067327 hasConcept C163764329 @default.
• W3113067327 hasConcept C181199279 @default.
• W3113067327 hasConcept C203014093 @default.
• W3113067327 hasConcept C2777513400 @default.
• W3113067327 hasConcept C2780366471 @default.
• W3113067327 hasConcept C55493867 @default.
• W3113067327 hasConcept C58471807 @default.
• W3113067327 hasConcept C71924100 @default.
• W3113067327 hasConcept C86803240 @default.
• W3113067327 hasConcept C90924648 @default.
• W3113067327 hasConceptScore W3113067327C126322002 @default.
• W3113067327 hasConceptScore W3113067327C142724271 @default.
• W3113067327 hasConceptScore W3113067327C159654299 @default.
• W3113067327 hasConceptScore W3113067327C160160445 @default.
• W3113067327 hasConceptScore W3113067327C163764329 @default.
• W3113067327 hasConceptScore W3113067327C181199279 @default.
• W3113067327 hasConceptScore W3113067327C203014093 @default.
• W3113067327 hasConceptScore W3113067327C2777513400 @default.
• W3113067327 hasConceptScore W3113067327C2780366471 @default.
• W3113067327 hasConceptScore W3113067327C55493867 @default.
• W3113067327 hasConceptScore W3113067327C58471807 @default.
• W3113067327 hasConceptScore W3113067327C71924100 @default.
• W3113067327 hasConceptScore W3113067327C86803240 @default.
• W3113067327 hasConceptScore W3113067327C90924648 @default.
• W3113067327 hasLocation W31130673271 @default.
• W3113067327 hasOpenAccess W3113067327 @default.
• W3113067327 hasPrimaryLocation W31130673271 @default.
• W3113067327 hasRelatedWork W10378053 @default.
• W3113067327 hasRelatedWork W12471632 @default.
• W3113067327 hasRelatedWork W15838475 @default.
• W3113067327 hasRelatedWork W15939362 @default.
• W3113067327 hasRelatedWork W19932237 @default.
• W3113067327 hasRelatedWork W3857228 @default.
• W3113067327 hasRelatedWork W5153245 @default.
• W3113067327 hasRelatedWork W5888450 @default.
• W3113067327 hasRelatedWork W913946 @default.
• W3113067327 hasRelatedWork W9546646 @default.
• W3113067327 isParatext "false" @default.
• W3113067327 isRetracted "false" @default.
• W3113067327 magId "3113067327" @default.
• W3113067327 workType "article" @default.